Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
11/30/2011 | EP1807383B1 Flavour modulating substances |
11/30/2011 | EP1806136B1 Medicinal composition for prevention of transition to operative treatment for prostatic hypertrophy |
11/30/2011 | EP1801231B1 Method of screening baff suppressor or inhibitor |
11/30/2011 | EP1778186B1 Method for preparation of poly-iclc and uses thereof |
11/30/2011 | EP1702626B1 Screening method for gamma-secretase inhibitors |
11/30/2011 | EP1663155B1 Dry powder composition comprising co-jet milled particles for pulmonary inhalation |
11/30/2011 | EP1638978B1 7-substituted camptothecin and camptothecin analogs and methods for preparing same |
11/30/2011 | EP1633735B1 Derivatives of piperidinyl- and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in therapeutics |
11/30/2011 | EP1633372B1 Vaccines, immunotherapeutics and methods for using the same |
11/30/2011 | EP1617836B1 Nutritional or therapeutic composition containing the compound oleuropeine or one of the derivatives thereof |
11/30/2011 | EP1613368B1 Carboxamide spirohydantoin cgrp receptor antagonists |
11/30/2011 | EP1551810B1 Diaryl-substituted cyclic urea derivatives having an mch-modulatory effect |
11/30/2011 | EP1530562B1 Optically active 1-(fluoro-,trifluoromethyl-or trifluoromethoxy-substituted phenyl)alkylamine n-monoalkyl derivatives and process for producing same |
11/30/2011 | EP1501496B1 Formulations containing amiodarone and sulfoalkyl ether cyclodextrin |
11/30/2011 | EP1469859B1 Use of polyunsaturated ketones for the treatment of psoriasis |
11/30/2011 | EP1461347B1 2-o-(-d-glucopyranosyl)ascorbic acid, process for its production, and foods and cosmetics containing compositions comprising it |
11/30/2011 | EP1409025B1 Vector encoding human globlin gene and use thereof in treatment of hemoglobinopathies |
11/30/2011 | EP1392823B1 Desaturase genes and uses thereof |
11/30/2011 | CN202052473U 过滤精制复方中药口服溶液的微孔滤膜装置 Filter refined compound Chinese medicine oral solution microporous membrane device |
11/30/2011 | CN202052058U 治疗骨质增生性骨关节病的药贴 Treatment of bone and joint disease osteoarthritis drugs posted |
11/30/2011 | CN202052054U 一种盐酸阿霉素缓释结构 One kind of doxorubicin hydrochloride sustained-release structure |
11/30/2011 | CN1984655B 可用于治疗血栓形成性疾病的p2y1受体脲拮抗剂 P2y1 receptors urea useful in the treatment of thrombotic diseases antagonists |
11/30/2011 | CN1980669B 含喹啉化合物的新组合物 New compositions containing quinoline compound |
11/30/2011 | CN1964975B Hiv整合酶抑制剂 Hiv integrase inhibitors |
11/30/2011 | CN1961879B 组成石杉碱甲鼻用原位凝胶喷雾剂的药物组合物、其制备方法及用途 Huperzine A composition in situ gel nasal sprays a pharmaceutical composition, methods for their preparation and use |
11/30/2011 | CN1878794B Ngf拮抗剂和阿片样药剂在治疗疼痛中的用途 Ngf antagonist and an opioid agent in the treatment of pain in use |
11/30/2011 | CN1870985B 用hdac抑制剂治疗癌症的方法 Methods of treating cancer using hdac inhibitor |
11/30/2011 | CN1656222B 反义iap核碱基寡聚物及其应用 Iap nucleobase antisense oligomer and its application |
11/30/2011 | CN102264903A 有效跳跃人杜兴肌营养不良前mRNA外显子45的方法和手段 Duchenne muscular dystrophy virtual hop human pre-mRNA exon 45 of the ways and means |
11/30/2011 | CN102264898A 微小rna的功能抑制方法 Small rna function Suppression |
11/30/2011 | CN102264752A 苯烷基-咪唑-二膦酸化合物 Phenylalkyl - imidazole - diphosphonic acid compounds |
11/30/2011 | CN102264745A 作为酪胺酸激酶抑制剂的稠合双环及多环嘧啶化合物 As the tyrosine kinase inhibitors and polycyclic fused bicyclic pyrimidine compounds |
11/30/2011 | CN102264743A Mlk抑制剂及其使用方法 Mlk inhibitors and methods of use |
11/30/2011 | CN102264742A 3-(3-嘧啶-2-基苄基)-1,2,4-三唑并[4,3-b]哒嗪衍生物 3- (3-pyrimidin-2-yl) -1,2,4-triazolo [4,3-b] pyridazine derivative |
11/30/2011 | CN102264741A 利考非隆的胆碱盐和氨丁三醇盐 Long non-profit test choline salt and tromethamine |
11/30/2011 | CN102264740A 一种吡咯[1,2-b]哒嗪衍生物及其作为hif调节剂的用途 A pyrrolo [1,2-b] pyridazine derivatives and their use as modulators of hif |
11/30/2011 | CN102264738A 螺吲哚满酮吡啶衍生物 Spiro indolinone derivative |
11/30/2011 | CN102264737A 抗病毒化合物 Antiviral compounds |
11/30/2011 | CN102264736A 作为TRK激酶抑制剂的取代的吡唑并[1,5-a]嘧啶化合物 As the substituted pyrazole TRK kinase inhibitors and [1,5-a] pyrimidine compounds |
11/30/2011 | CN102264735A 制备帕潘立酮以及它的草酸盐的一步方法 -Step process for preparing paliperidone and its oxalate |
11/30/2011 | CN102264734A 生物碱氨基酯衍生物及其药用组合物 Alkaloid aminoester derivatives and pharmaceutical compositions |
11/30/2011 | CN102264732A PI3K/mTOR激酶抑制剂 PI3K / mTOR kinase inhibitor |
11/30/2011 | CN102264731A 1,2,4-*二唑衍生物及其治疗用途 * 1,2,4-oxadiazole derivatives and their therapeutic use |
11/30/2011 | CN102264729A 6-(1-甲基-1h-吡唑-4-基)-2-{3-[5-(2-吗啉-4-基-乙氧基)-嘧啶-2-基]-苄基}-2h-哒嗪-3-酮磷酸二氢盐的新多晶型物及其制备方法 6- (1-methyl--1h- pyrazol-4-yl) -2- {3- [5- (2-morpholin-4-yl - ethoxy) - pyrimidin-2-yl] - benzyl } -2h- pyridazin-3-one dihydrogen phosphate new polymorph and its preparation method |
11/30/2011 | CN102264728A 用于调节ire1、src和abl活性的方法和组合物 The method used to adjust ire1, src and abl activity and composition |
11/30/2011 | CN102264727A 哒嗪酮衍生物 Pyridazinone derivatives |
11/30/2011 | CN102264726A 新的舒尼替尼盐 New sunitinib salt |
11/30/2011 | CN102264725A 蛋白激酶抑制剂 Protein kinase inhibitors |
11/30/2011 | CN102264723A 作为P2X<sub>7</sub>调节剂的二氢吡啶酮酰胺 As P2X <sub> Dihydropyridones amide 7 </ sub> modifier |
11/30/2011 | CN102264722A 作为P2X<sub>7</sub>调节剂的二氢吡啶酮酰胺 As P2X <sub> Dihydropyridones amide 7 </ sub> modifier |
11/30/2011 | CN102264721A 用作atr激酶抑制剂的化合物 Compounds useful as kinase inhibitors atr |
11/30/2011 | CN102264720A 用于治疗癌症的异吲哚啉化合物 For the treatment of cancer isoindoline compound |
11/30/2011 | CN102264716A 用于预防和治疗骨相关疾病的取代的苯并呋喃并色烯和相关化合物 For the prevention and treatment of bone related diseases substituted benzofuran and related compounds and chromene |
11/30/2011 | CN102264713A 用于治疗癌症的二(苯丙素)甘油衍生物 For the treatment of cancer two (phenylpropanoid) glycerol derivatives |
11/30/2011 | CN102264710A 半胱氨酸蛋白酶抑制剂 Cystatin |
11/30/2011 | CN102264707A 新型双环型杂环化合物 Novel bicyclic heterocyclic compounds |
11/30/2011 | CN102264706A 二聚的1-芳基吡唑衍生物 1-aryl-pyrazole derivatives dimeric |
11/30/2011 | CN102264704A 异喹啉衍生物 Isoquinoline derivatives |
11/30/2011 | CN102264703A 作为β2肾上腺素受体促效剂的5-(2-{[6-(2,2-二氟-2-苯基乙氧基)己基]胺基}-1-羟乙基)-8-羟基喹啉-2(1H)-酮的甲磺酸盐 As a β2 adrenergic receptor agonist 5- (2 - {[6- (2,2-difluoro-2-phenylethoxy) hexyl] amino} -1-hydroxyethyl) -8- hydroxyquinoline -2 (1H) - one methanesulfonate |
11/30/2011 | CN102264702A 作为P2X<sub>7</sub>调节剂的二氢吡啶酮酰胺 As P2X <sub> Dihydropyridones amide 7 </ sub> modifier |
11/30/2011 | CN102264701A 作为P2X<sub>7</sub>调节剂的二氢吡啶酮脲 As P2X <sub> Dihydropyridones urea 7 </ sub> modifier |
11/30/2011 | CN102264700A 可用作治疗自身免疫和炎性疾病的药物的二氢吡啶酮酰胺 Dihydropyridones amides useful as the treatment of autoimmune and inflammatory diseases of |
11/30/2011 | CN102264699A 新的亚苄基-吲哚啉酮及它们的医疗和诊断用途 New benzylidene - indolinone and their medical and diagnostic uses |
11/30/2011 | CN102264695A 作为半胱氨酸蛋白酶抑制剂的含卤代烷基化合物 The halogenated alkyl compound containing a cysteine protease inhibitor |
11/30/2011 | CN102264395A 含有曲普坦化合物和木糖醇的液体医药组合物 Liquid pharmaceutical compositions containing the compounds and xylitol triptan |
11/30/2011 | CN102264388A 含有特异性识别cd38的抗体和长春新碱的抗肿瘤组合 Anti-tumor composition comprising an antibody that specifically recognize cd38 and vincristine |
11/30/2011 | CN102264387A 含有特异性识别cd38的抗体和环磷酰胺的抗肿瘤组合 Anti-tumor composition comprising an antibody that specifically recognize cd38 and cyclophosphamide |
11/30/2011 | CN102264386A 含特异性识别cd38的抗体和阿糖胞苷的抗肿瘤组合 Containing a combination of anti-tumor antibodies that specifically recognize and cytarabine cd38 |
11/30/2011 | CN102264385A 含特异性识别cd38的抗体和苯丙氨酸氮芥的抗肿瘤组合 Anti-tumor composition containing an antibody that specifically recognizes cd38 and melphalan |
11/30/2011 | CN102264382A 抗生素协同作用 Antibiotic synergy |
11/30/2011 | CN102264380A 低浓度的营养组合物 Low concentrations of a nutritional composition |
11/30/2011 | CN102264376A 用于封装的浓松针提取物组合物 Pine needle is used to encapsulate the concentrated extract composition |
11/30/2011 | CN102264374A 5′和2′双取代的核苷和由其制备的低聚化合物 5 'and 2' substituted nucleoside and double oligomeric compounds prepared therefrom |
11/30/2011 | CN102264373A 用于原位肿瘤破坏疗法的免疫刺激性皂苷类 Therapy for in situ tumor destruction immunostimulatory saponins |
11/30/2011 | CN102264371A 作为fak抑制剂的吡唑基氨基吡啶 As fak inhibitors pyrazolyl aminopyridine |
11/30/2011 | CN102264370A 投与眼的flap抑制剂的局部调配物 Topical formulations administered eye flap inhibitors |
11/30/2011 | CN102264369A 作为α2C肾上腺素受体激动剂的3,4-二氢-1,4-苯并噁嗪、3,4-二氢-1,4-苯并噻嗪和1,2,3,4-四氢-喹喔啉衍生物 As α2C adrenergic receptor agonists 3,4-dihydro-1,4-benzoxazine, 3,4-dihydro-1,4-benzothiazine and 1,2,3,4- Hydrogen - quinoxaline derivatives |
11/30/2011 | CN102264368A 极光激酶抑制剂与抗cd20抗体的组合 Aurora kinase inhibitor in combination with an anti-cd20 antibody |
11/30/2011 | CN102264367A 新用途 New uses |
11/30/2011 | CN102264366A 含有芝麻素类和表没食子儿茶素没食子酸酯的组合物 Containing sesamin class and Epigallocatechin gallate compositions |
11/30/2011 | CN102264365A 吸入用干粉药物组合物 Dry powder pharmaceutical composition for inhalation |
11/30/2011 | CN102264364A 一种多环化合物及其相关方法 A multi-ring compounds and related method |
11/30/2011 | CN102264363A S1p受体激动剂的给药方案 S1p receptor agonist dosing regimen |
11/30/2011 | CN102264362A 预防或治疗与更年期有关的症状的植物雌激素组合物 Prevention or treatment of symptoms associated with menopause, phytoestrogens composition |
11/30/2011 | CN102264361A 预防或减少癌发生或氧化性应激的方法 The method of preventing or reducing cancer or oxidative stress |
11/30/2011 | CN102264360A 预防或减少结肠癌发生的方法 The method of preventing or reducing the occurrence of colon cancer |
11/30/2011 | CN102264359A S1p受体激动剂的给药方案 S1p receptor agonist dosing regimen |
11/30/2011 | CN102264358A 包含布洛芬、伪麻黄碱和扑尔敏的药物组合物 Contains ibuprofen, pseudoephedrine and chlorpheniramine pharmaceutical composition |
11/30/2011 | CN102264357A 黑色素产生抑制剂 Melanin inhibitor |
11/30/2011 | CN102264355A 对乙酰氨基酚/曲马多口服延释剂型 Acetaminophen / tramadol extended release oral dosage form |
11/30/2011 | CN102264354A 用于治疗5-HT<sub>2A</sub>5-羟色胺受体相关障碍的5-HT<sub>2A</sub>5-羟色胺受体调节剂组合物 2A </ sub> 5- HT receptor related disorders 5-HT <sub> 2A </ sub> 5- HT receptor modulators compositions for treating 5-HT <sub> |
11/30/2011 | CN102264348A 生物活性提高的白藜芦醇制剂 Increased biological activity of resveratrol formulation |
11/30/2011 | CN102264346A 用于通过颊透粘膜途径来施用降血脂药的制剂 Buccal transmucosal route used by lipid-lowering drug formulations administered |
11/30/2011 | CN102264344A 递送有效浓度的活性剂至眼睛后段的局部眼用溶液组合物 Topical ophthalmic solution composition to the eye after delivering an effective concentration of the active agent segment |
11/30/2011 | CN102264228A 用于抗糖尿病药的新的环状苯并咪唑衍生物 New benzimidazole derivatives of the cyclic anti-diabetic drugs for |
11/30/2011 | CN102260692A 一种八氢番茄红素脱氢酶基因及其应用 One kind of phytoene desaturase gene and its application |
11/30/2011 | CN102260313A 无定形态人参皂苷Rb1及其制备方法 Amorphous ginsenosides Rb1 and its preparation method |
11/30/2011 | CN102260308A 左旋异戊酰螺旋霉素iii、其制剂、制备方法及应用 L isovaleryl spiramycin iii, its preparation, preparation method and application |
11/30/2011 | CN102260305A 4<sup>”</sup>-((取代苯甲酰胺基)烷基)氨基甲酸酯阿奇霉素11-氨基甲酸酯衍生物及其中间体 4 <sup> "</ sup> - ((substituted benzoyl amino) alkyl) carbamate azithromycin 11- carbamate derivatives and intermediates |
11/30/2011 | CN102260297A 海藻糖酰胺衍生物及其制备方法与应用 Trehalose derivatives and their preparation and use |